ResearcherZhongshan HospitalNo recent work listed
Yu Hu
Matched on ORCID iD 0000-0003-3883-3887; OpenAlex author ID A5101905282.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 4
- Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. Last author DOI 10.1186/s13046-018-0818-z↗
- Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.17519↗
- SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. Last author DOI 10.1007/s13277-015-3047-5↗
- Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Last author DOI 10.3892/ijo.2012.1524↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yan Sun · 4 shared papers, 2012–2018
- Paper Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. DOI 10.1186/s13046-018-0818-z↗
- Paper Role of transgelin-2 in diabetes-associated pancreatic ductal adenocarcinoma. DOI 10.18632/oncotarget.17519↗
- Paper SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. DOI 10.1007/s13277-015-3047-5↗
- Yuhong Zhou · 2 shared papers, 2015–2017
- Yaozong Yuan · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.